Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Mentor Seeks Aesthetic Medicine Acquisitions For Near-Term Growth

This article was originally published in The Gray Sheet

Executive Summary

Mentor says it is on the lookout for acquisitions and licensing deals in the aesthetics arena as it waits to see if FDA will approve its silicone breast implants

You may also be interested in...



Enzi Report Finds No Major Concerns With FDA’s Silicone Implant Actions

A Senate investigation into FDA's conditional approval of silicone gel-filled breast implants concludes that the agency followed appropriate review procedures

Mentor Finds Prospective Buyer For Urology Business In Coloplast

Mentor signaled March 27 that it has found a buyer for its urology business, furthering its shift to aesthetics medicine

Inamed Receives Silicone Breast Implant “Approvable” Letter From FDA

Inamed's silicone gel-filled breast implants inched closer to the market with the receipt of an FDA "approvable" letter, after the firm removed the controversial Style 153 implants from its PMA application

Related Content

UsernamePublicRestriction

Register

MT023878

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel